{"entity":{"id":"velsera","kind":"company","name":"Velsera (Seven Bridges and Pierian)","aka":[],"tldr":"Genomics cloud and clinical interpretation company formed from Seven Bridges, Pierian, and UgenTec in 2023; operates the NCI Cancer Genomics Cloud.","summary":"Velsera, based in Boston, is a genomics cloud and clinical interpretation company formed in 2023 from Seven Bridges, Pierian and UgenTec, and it operates the NCI Cancer Genomics Cloud. It provides a bioinformatics platform for research and for clinical next-generation sequencing reporting. OnCo links it to clinical NGS bioinformatics and variant interpretation and to genomics cloud and secure research environments. Whether a merged research and clinical platform serves either market as well as the specialists did is the open question. The genomics cloud technology page carries the wider picture.","asOf":"2026-09-08","links":[{"label":"Official website","url":"https://velsera.com"}],"tags":["supporting"],"related":[],"cancers":[],"sections":["diagnostics","ai-computation"],"technologies":["ngs-bioinformatics-software","genomics-cloud-platforms"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Boston, MA","country":"US","companyType":"ai-software","website":"https://velsera.com","investors":[],"funding":[]},"route":"/companies/velsera/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"ngs-bioinformatics-software","kind":"technology","name":"Clinical NGS bioinformatics and variant interpretation","route":"/technologies/ngs-bioinformatics-software/"},{"id":"genomics-cloud-platforms","kind":"technology","name":"Genomics cloud and secure research environments","route":"/technologies/genomics-cloud-platforms/"}]}}